Steven Cha
Chief Tech/Sci/R&D Officer chez PROCESSA PHARMACEUTICALS, INC.
Postes actifs de Steven Cha
Sociétés | Poste | Début | Fin |
---|---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/04/2024 | - |
Historique de carrière de Steven Cha
Anciens postes connus de Steven Cha
Sociétés | Poste | Début | Fin |
---|---|---|---|
IMUGENE LIMITED | Chief Tech/Sci/R&D Officer | 01/02/2022 | 01/06/2022 |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Chief Tech/Sci/R&D Officer | - | - |
Formation de Steven Cha
University of California San Diego | Undergraduate Degree |
Tufts University School of Medicine | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Australie | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
IMUGENE LIMITED | Health Technology |
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
- Bourse
- Insiders
- Steven Cha
- Expérience